ioxaglate has been researched along with Anaphylaxis in 10 studies
Ioxaglic Acid: A low-osmolar, ionic contrast medium used in various radiographic procedures.
ioxaglic acid : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an acetyl(methyl)amino group at the 5-position.
Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
Excerpt | Relevance | Reference |
---|---|---|
"Coronary vasospasm is infrequent during anaphylaxis reaction." | 1.31 | [Iodic allergic reaction with vasospasm occluded coronary during coronarography]. ( Allouch, P; Belaouchi, F; Bourgeois, B; Monsegu, J; Richard, P; Schiano, P; Spaulding, C, 2002) |
"Any patient who has had a severe anaphylactoid reaction following injection of a contrast agent should undergo an allergological assessment to confirm the diagnosis and identify the culprit contrast agent." | 1.31 | [Severe reactions to iodinated contrast agents: is anaphylaxis responsible?]. ( Dewachter, P; Mouton-Faivre, C, 2001) |
"To investigate the mechanisms of anaphylactoid reactions to radiocontrast media, in vitro mediator release induced by three iodinated contrast agents was examined using peripheral blood basophils and mast cells purified from human lung parenchyma, heart, and skin tissues." | 1.29 | Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue. ( Adt, M; de Crescenzo, G; Genovese, A; Lamparter-Schummert, B; Marone, G; Patella, V; Stellato, C, 1996) |
"A case is described of an anaphylactic reaction to "Hexabrix 320" radiographic contrast medium in a patient undergoing routine coronary angiography." | 1.27 | Anaphylaxis following "Hexabrix" during routine coronary angiography. ( Langton, JA; Magee, P; Sedgwick, J; Sutton, R, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schiano, P | 1 |
Bourgeois, B | 1 |
Richard, P | 1 |
Belaouchi, F | 1 |
Monsegu, J | 1 |
Allouch, P | 1 |
Spaulding, C | 1 |
Sendo, T | 1 |
Sumimura, T | 1 |
Itoh, Y | 1 |
Goromaru, T | 1 |
Aki, K | 1 |
Yano, T | 1 |
Oike, M | 1 |
Ito, Y | 1 |
Mori, S | 1 |
Nishibori, M | 1 |
Oishi, R | 1 |
Osawa, M | 1 |
Satoh, F | 1 |
Horiuchi, H | 1 |
Tian, W | 1 |
Kugota, N | 1 |
Hasegawa, I | 1 |
Bennasr, S | 1 |
Magnier, S | 1 |
Hassan, M | 1 |
Jacqz-Aigrain, E | 1 |
Genovese, A | 1 |
Stellato, C | 1 |
Patella, V | 1 |
Lamparter-Schummert, B | 1 |
de Crescenzo, G | 1 |
Adt, M | 1 |
Marone, G | 1 |
Dewachter, P | 1 |
Mouton-Faivre, C | 1 |
Bertrand, PR | 1 |
Soyer, PM | 1 |
Rouleau, PJ | 1 |
Alison, DP | 1 |
Billardon, MJ | 1 |
Doyama, K | 1 |
Hirose, K | 1 |
Kosuga, K | 1 |
Kawakami, Y | 1 |
Morikawa, M | 1 |
Tomioka, N | 1 |
Watanabe, Y | 1 |
Zimmerer, J | 1 |
Mainos, D | 1 |
Tittor, W | 1 |
Spannagel, B | 1 |
Langton, JA | 1 |
Magee, P | 1 |
Sedgwick, J | 1 |
Sutton, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN)[NCT02673840] | Phase 4 | 110 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ioxaglate and Anaphylaxis
Article | Year |
---|---|
Comparative randomized double-blind study of hydroxyzine versus placebo as premedication before injection of iodinated contrast media.
Topics: Aged; Anaphylaxis; Double-Blind Method; Female; Humans; Hydroxyzine; Ioxaglic Acid; Male; Middle Age | 1992 |
9 other studies available for ioxaglate and Anaphylaxis
Article | Year |
---|---|
[Iodic allergic reaction with vasospasm occluded coronary during coronarography].
Topics: Aged; Anaphylaxis; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Va | 2002 |
Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.
Topics: Actins; Anaphylaxis; Animals; Antigens, CD; Aorta; Benzamidines; Cadherins; Calcium Signaling; Capil | 2003 |
Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases.
Topics: Aged; Analgesics; Anaphylaxis; Anti-Bacterial Agents; Antibodies; Case-Control Studies; Cefotiam; Co | 2008 |
[Anaphylactic shock and low osmolarity contrast medium].
Topics: Anaphylaxis; Female; Humans; Infant; Ioxaglic Acid; Osmolar Concentration; Remission Induction | 1994 |
Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Topics: Adult; Anaphylaxis; Basophils; Cell Separation; Contrast Media; Female; Histamine Release; Humans; I | 1996 |
[Severe reactions to iodinated contrast agents: is anaphylaxis responsible?].
Topics: Aged; Aged, 80 and over; Anaphylaxis; Contrast Media; Female; Humans; Iohexol; Ioxaglic Acid; Male; | 2001 |
Coronary artery spasm induced by anaphylactoid reaction to a new low osmolar contrast medium.
Topics: Anaphylaxis; Coronary Angiography; Coronary Vasospasm; Electrocardiography; Female; Humans; Ioxaglic | 1990 |
[A life-threatening contrast-medium reaction during ERCP].
Topics: Adult; Anaphylaxis; Cholangiopancreatography, Endoscopic Retrograde; Diatrizoate Meglumine; Female; | 1990 |
Anaphylaxis following "Hexabrix" during routine coronary angiography.
Topics: Aged; Anaphylaxis; Angiography; Coronary Angiography; Humans; Ioxaglic Acid; Male | 1988 |